Resistance testing of clinical varicella-zoster virus strains

Antiviral Research

Volumn 90, Issue 3, 2011, Pages 242-247

  Sauerbrei, Andreas ^a   Taut, Johanna ^a   Zell, Roland ^a   Wutzler, Peter ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

DNA polymerase; Genotypic resistance; Phenotypic resistance; Thymidine kinase; Varicella zoster virus

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; CIDOFOVIR; DNA POLYMERASE; FOSCARNET; PENCICLOVIR; THYMIDINE KINASE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ANTIVIRAL SUSCEPTIBILITY; ARTICLE; CHILD; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; INFANT; MALE; NONHUMAN; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION; VIRUS STRAIN;

ACYCLOVIR; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA-DIRECTED DNA POLYMERASE; DRUG RESISTANCE, VIRAL; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MUTATION; POLYMORPHISM, GENETIC; THYMIDINE KINASE; VIRAL PROTEINS; YOUNG ADULT;

HUMAN HERPESVIRUS 3;

EID: 79955811013     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.04.005     Document Type: Article

References (42)

1. Arvin, A.M., 1999. Chickenpox (varicella). In: Wolff, M.H., Schünemann, S., Schmidt, A. (Eds.), Varicella-Zoster Virus. Molecular Biology, Pathogenesis, and Clinical Aspects. Contrib. Microbiol. Karger, Basel, 3, 96-110.
2. Au W.Y., Ma S.Y., Cheng V.C., Ooi C.G., Lie A.K. Disseminated zoster, hyponatraemia, severe abdominal pain and leukemia relapse: recognition of a new clinical quartet after bone marrow transplantation. Br. J. Dermatol. 2003, 149:862-865.
3. Bacon T.H., Levin M.J., Leary J.J., Sarisky R.T., Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin. Mcrobiol. Rev. 2003, 16:114-128.
4. Balfour H.H., Benson C., Braun J., Cassens B., Erice A., Friedman-Kien A., Klein T., Polsky B., Safrin S. Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J. Acquir. Immune Defic. Syndr. 1994, 7:254-260.
5. Beards G., Graham C., Pillay D. Investigation of vesicular rashes for HSV and VZV by PCR. J. Med. Virol. 1998, 54:155-157.
6. Bleymehl, K., Ciantl, J., Schmidt-Chanasit, J., 2011. Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet. Med. Microbiol. Immunol. doi:10.1007/s00430-011-0191-4.
7. Bohn, K., Zell, R., Schacke, M., Wutzler, P., Sauerbrei, A., in press. Gene polymorphism of thymidine kinase and DNA polymerase in clinical strains of herpes simplex virus. Antiviral Ther.
8. Boivin G., Edelman C.K., Pedneault L., Talarico C.L., Biron K.K., Balfour H.H. Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster virus isolated from persons with AIDS. J. Infect. Dis. 1994, 170:68-75.
9. Breuer J., Grose C., Norberg P., Tipples G., Schmid D.S. A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. J. Gen. Virol. 2010, 91:821-828.
10. Bryan C.L., Prichard M.N., Daily S., Jefferson G., Hartline C., Cassady K.A., Hilliard L., Shimamura M. Acyclovir-resistant chronic verrucous vaccine strain varicella in a patient with neuroblastoma. Pediatr. Infect. Dis. J. 2008, 27:946-948.
11. Burrel S., Deback C., Agut H., Boutolleau D. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob. Agents Chemother. 2010, 54:4833-4842.
12. Crassard N., Souillet A.L., Morfin F., Thouvenot D., Claudy A., Bertrand Y. Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant. Acta Paediatr. 2000, 89:1497-1499.
13. Chrisp P., Clissold S.P. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs 1991, 41:104-129.
14. De Clercq E. Antiviral drugs in current clinical use. J. Clin. Virol. 2004, 22:115-133.
15. Dlugosch D., Eis-Hübinger A.M., Kleim J.P., Kaiser R., Bierhoff E., Schneweis K.E. Diagnosis of acute and latent varicella-zoster virus infections using polymerase chain reaction. J. Med. Virol. 1991, 35:136-141.
16. Fillet A.M., Dumont B., Caumes E., Visse B., Agut H., Bricaire F., Huraux J.M. Acyclovir-resistant varicella-zoster virus: phenotypic and genotypic characterization. J. Med. Virol. 1998, 55:250-254.
17. Fillet A.M., Visse B., Caumes E., Dumont B., Gentilini M., Huraux J.M. Foscarnet-resistant multidermatomal zoster in a patient with AIDS. Clin. Infect. Dis. 1994, 21:1348-1349.
18. Gershon A., Mervish N., LaRussa P., Steinberg S., Lo S.H., Hodes D., Fikrig S., Bonagura V., Bakshi S. Varicella-zoster virus infection in children with underlying HIV infection. J. Infect. 1997, 176:1496-1500.
19. Gilden D., Nagel M.A., Mahalingam R., Mueller N.H., Braszeau E.A., Pugazhenthi S., Cohrs R.J. Clinical and molecular aspects of varicella-zoster virus infection. Future Neurol. 2009, 4:103-117.
20. Gnann J.W. Varicella-zoster virus: atypical presentations and unusual complications. J. Infect. Dis. 2002, 186(Suppl. 1):S91-S98.
21. Gross G., Schöfer H., Wassilew S., Friese K., Timm A., Guthoff R., Pau H.W., Malin J.P., Wutzler P., Doerr H.W. Herpes zoster guideline of the German Dermatology Society (DDG). J. Clin. Virol. 2003, 26:277-289.
22. Hatchette T., Tipples G., Peters G., Alsuwaidi A., Zhou J., Mailam T.L. Foscarnet salvage therapy for acyclovir-resistant varicella zoster. Report of a novel thymidine kinase mutation and review of the literature. Pediatr. Infect. Dis. J. 2008, 27:75-77.
23. Jacobson M.A., Berger T.G., Fikrig S., Becherer P., Moohr J.W., Stanat S.C., Biron K.K. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann. Int. Med. 1990, 112:187-191.
24. Kamiyama T., Kurokawa M., Shiraki K. Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir. J. Gen. Virol. 2001, 82:2761-2765.
25. Linnemann C.C., Biron K.K., Hoppenjans W.G., Solinger A.M. Emergence of acyclovir-resistant varicella-zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS 1990, 4:577-579.
26. Loparev V., Martro E., Rubtcova E., Rodrigo C., Piette J.C., Caumes E., Vernant J.P., Schmid D.S., Fillet A.M. Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J. Clin. Microbiol. 2007, 45:559-563.
27. Lyall E.G., Ogilvie M.M., Smith N.M., Burns S. Acyclovir resistant varicella zoster and HIV infection. Arch. Dis. Childh. 1994, 70:133-135.
28. Morfin F., Thouvenout D. Herpes simplex virus resistance to antiviral drugs. J. Clin. Virol. 2003, 26:29-37.
29. Morfin F., Thouvenout D., De Turenne-Tessier M., Lina B., Aymard M., Ooka T. Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir. Antimicrob. Agents Chemother. 1999, 43:2412-2416.
30. Pahwa S., Biron K., Lim W., Swenson P., Kaplan M.H., Sadick N., Pahwa R. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA 1988, 260:2879-2882.
31. Quinlivan M., Hawrami K., Barrett-Muir W., Aaby P., Arvin A., Chow V.T., John T.J., Matondo P., Peiris M., Poulsen A., Siqueira M., Takahashi M., Talukder Y., Yamanishi K., Leedham-Green M., Scott F.T., Thomas S.L., Breuer J. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J. Infect. Dis. 2002, 186:888-894.
32. Safrin S., Berger T.G., Gilson I., Wolfe P.R., Wofsy C.B., Mills J., Biron K.K. Foscarnet therapy in fife patients with AIDS and acyclovir-resistant varicella-zoster virus infection. Ann. Int. Med. 1991, 115:19-21.
33. Saint-Léger E., Caumes E., Breton G., Douard D., Saiag P., Huraux J.M., Bricaire F., Agut H., Fillet A.M. Clinical and virologic characterization of acyclovir-resistant varicella-zoster viruses isolated from 11 patients with acquired immunodeficiency syndrome. Clin. Infect. Dis. 2001, 33:2061-2067.
34. Sauerbrei A., Eichhorn U., Schacke M., Wutzler P. Laboratory diagnosis of herpes zoster. J. Clin. Virol. 1999, 14:31-36.
35. Sauerbrei A., Philipps A., Zell R., Wutzler P. Genotyping of varicella-zoster virus strains after serial passages in cell culture. J. Virol. Methods 2007, 145:80-83.
36. Sauerbrei, A., Stefanski, J., Philipps, A., Krumbholz, A., Zell, R., Wutzler, P., 2011. Monitoring prevalence of varicella-zoster virus clades in Germany. Med. Microbiol. Immunol. doi:10.1007/s00430-010-0178-6.
37. Sauerbrei A., Zell R., Philipps A., Wutzler P. Genotypes of varicella-zoster virus wild-type strains in Germany. J. Med. Virol. 2008, 80:1123-1130.
38. Sauerbrei A., Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy - current concepts of prevention, diagnosis and therapy. Part 2: varicella-zoster virus infections. Med. Microbiol. Immunol. 2007, 196:95-102.
39. Snoeck R., Gérard M., Sadzot-Delvaux C., Andrei G., Balzarini J., Reymen D., Ahadi N., De Bruyn J.M., Piette J., Rentier B., Clumeck N., De Clercq E. Meningoradiculoneuritis due to acyclovir-resistant varicella zoster virus in an acquired immune deficiency syndrome patient. J. Med. Virol. 1994, 42:338-347.
40. Talarico C.L., Phelps W.C., Biron K. Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS. J. Virol. 1993, 67:1024-1033.
41. Visse B., Dumont B., Huraux J.M., Fillet A.M. Single amino acid change in DNA polymerase is associated with foscarnet resistance in a varicella-zoster virus strain recovered from a patient with AIDS. J. Infect. Dis. 1998, 178(Suppl. 1):S55-S57.
42. Wunderli W., Miner R., Wintsch J., von Gunten S., Hirsch H.H., Hirschel B. Outer retinal necrosis due to a strain of varicella-zoster virus resistant to acyclovir, gancyclovir, and sorivudine. Clin. Infect. Dis. 1996, 22:864-865.